Shares of Elevance Health Inc. ELV slipped 1.63% to $427.19 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.08% to ...

Wells Fargo analyst Stephen Baxter reiterated a Buy rating on Elevance Health (ELV – Research Report) yesterday and set a price target of ...

Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future ...

Elevance Health (NYSE:ELV – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Thursday. Several other ...

Elevance Health (ELV) stock rises as CFO cites underestimated Q1 profit forecasts from analysts for the company at Barclays ...

We recently compiled a list of the Top 10 Health Insurance Stocks To Buy. In this article, we are going to take a look at ...

Argus upgraded Elevance Health (ELV) to Buy from Hold with a $450 price target Light Up your Portfolio with Spark:Easily identify stocks' risks ...

Elevance Health Inc. closed 26.44% below its 52-week high of $567.26, which the company reached on September 3rd.

Elevance Health settled a class-action lawsuit over denial of coverage for minimally invasive sacroiliac joint fusion surgery ...

Elevance Health ELV has outperformed the market over the past 15 years by 2.24% on an annualized basis producing an average ...

Elevance Health Inc. signed a class settlement valued at more than $2.5 million in a lawsuit saying it wrongly denied ...